Imidazole propionate: Cause and cure in atherosclerosis?
Level V
Where this comes from
- Record sourced from PubMed, PMID 41061667.
- Also identified by DOI 10.1016/j.cmet.2025.08.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atherosclerosis remains the leading type of cardiovascular disease, yet its pathogenesis is not completely understood, hindering the development of effective early diagnostics and therapeutics. Recent work by Mastrangelo et al. in Nature has identified a novel driver of atherosclerosis, the gut microbiota-derived metabolite imidazole propionate, which triggers atherosclerosis via the imidazoline-1 receptor in myeloid cells.
Medical subject headings
- Atherosclerosis
- Imidazoles
- Propionates